Boston, MA · Founded 2019 · Privately Held (backing)
Developer of transdermal drug delivery technology designed to reformulate clinically validated molecules into needle-free therapeutics for chronic diseases. Anodyne Nanotech is based in Boston, MA and was founded in 2019. Its last reported valuation was $7 million in Aug 2020. It has raised $9.6 million across 3 recorded rounds; the latest was a $12.6 million early-stage round in May 2026.
Last reported valuation
$7.0M
Oct 2026
Priced at
—
Total raised
$9.6M
Last round
Early Stage VC
May 2026
Cap table — not yet on record
Anodyne Nanotech's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Anodyne Nanotech with a free account
·Watch Anodyne Nanotech: the Monday email on marks, rounds and moves
Where does Anodyne Nanotech's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Anodyne Nanotech's 3 recorded funding rounds.
